1-4 of 4
David A. Tuveson
Close
Sort by
Journal Articles

Expression of oncogenic K-ras from its endogenous promoter leads to a partial block of erythroid differentiation and hyperactivation of cytokine-dependent signaling pathways

Brief Report
Jing Zhang, Yangang Liu, Caroline Beard, David A. Tuveson, Rudolf Jaenisch, Tyler E. Jacks, Harvey F. Lodish
Journal: Blood
Blood (2007) 109 (12): 5238–5241.
https://doi.org/10.1182/blood-2006-09-047050
Published: 2007
Journal Articles

Somatic activation of a conditional Kras G12D allele causes ineffective erythropoiesis in vivo

Brief Report
Benjamin S. Braun, Joehleen A. Archard, Jessica A. G. Van Ziffle, David A. Tuveson, Tyler E. Jacks, Kevin Shannon
Journal: Blood
Blood (2006) 108 (6): 2041–2044.
https://doi.org/10.1182/blood-2006-01-013490
Published: 2006
Includes: Supplemental data
Journal Articles

In Vitro Analysis of Myeloid Proliferation Caused by Oncogenic Kras.

Benjamin S. Braun, MD, PhD, Joehleen Gavin, David A. Tuveson, MD, PhD, Tyler E. Jacks, PhD
Journal: Blood
Blood (2004) 104 (11): 795.
https://doi.org/10.1182/blood.V104.11.795.795
Published: 2004
Journal Articles

Anemia and Ineffective Erythropoiesis Caused by Somatic RAS Mutation.

Benjamin S. Braun, MD, PhD, Jessica van Ziffle, Joehleen Gavin, David A. Tuveson, MD, PhD, Tyler Jacks, PhD, Kevin Shannon, MD
Journal: Blood
Blood (2004) 104 (11): 3419.
https://doi.org/10.1182/blood.V104.11.3419.3419
Published: 2004